Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.6.3535

Genetic Deletions of GSTM1 and GSTT1 in Head and Neck Cancer: Review of the Literature from 2000 to 2012  

Masood, Nosheen (Environmental Sciences Department, Fatima Jinnah Women University)
Yasmin, Azra (Environmental Sciences Department, Fatima Jinnah Women University)
Kayani, Mahmood A. (Department of Biosciences, COMSATS Institute of Information Technology)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.6, 2013 , pp. 3535-3539 More about this Journal
Abstract
Head and neck cancer is one of the leading causes of deaths worldwide. Two genes GSTM1 and GSTT1 involved in phase II of carcinogen detoxification have been frequently studied in the literature. Their null genotypes are thought to be associated with increased head and neck cancer risk. However, the published reviews are not up to date and many important papers have been skipped. The current literature review was restricted to the null genotypes of the GSTM1 and GSTT1 genes with special emphasis on the genotypic status. We found that the size of study sample varied greatly and the oral cavity cancer was more influenced by GSTM1 and GSTT1 gene deletions. With respect to ethnicity Asians are more prone to head and neck cancers with these null genotypes as compared to Europeans and Americans. The current review showed significant associations (OR=9.0, 95%CI; 1.4-9.5; OR=3.7, 95%CI; 1.4-9.5) of GSTM1 and GSTT1 null genotypes with head and neck cancers. Review confirms the data of previous reviews that GSTM1 and GSTT1 gene polymorphisms may be risk factors for cancer initiation.
Keywords
GSTM1; GSTT1; head and neck cancer;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Hong YJ, Lee JK, Lee GH, et al (2000). Influence of glutathione Stransferase M1 and T1 genotypes on larynx cancer risk among Korean smokers. Clin Chem Lab Med, 38, 917-9.
2 Jun T, Ming Y, Xin N, et al (2010). Genetic polymorphisms in cytochrome P450 genes are associated with an increased risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population. Cancer Genet Cytogenet, 196, 76-82.   DOI   ScienceOn
3 Kietthubthew S, Sriplung H, Au WW (2001). Genetic and environmental interactions on oral cancer in Southern Thailand. Environ Mol Mutagen, 37, 111-6.   DOI   ScienceOn
4 Ko Y, Abel J, Harth V, et al (2001). Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Cancer Res, 61, 4398-404.
5 Leme CV, Raposo LS, Ruiz MT, et al (2010). GSTM1 and GSTT1 genes analysis in head and neck cancer patients. Rev Assoc Med Bras, 56, 299-303.   DOI   ScienceOn
6 Majumder M, Sikdar N, Paul RR, et al (2005). Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes: one on each of two loci, GSTM3 and XRCC1 (codon 280). Cancer Epidemiol Biomarkers Prev, 14, 2106-12.   DOI   ScienceOn
7 Masood N, Ishrat M, Malik FA, Kayani MA (2010). Association of GSTM1 and GSTT1 gene deletions with head and neck cancer in Pakistan: a case control study. Asian Pac J Cancer Prev, 11, 881-5.
8 McWilliams JE, Evans AJ, Beer TM, et al (2000). Genetic polymorphisms in head and neck cancer risk. Head Neck, 22, 609-17.   DOI   ScienceOn
9 Gajecka M, Rydzanicz M, Jaskula-Sztul R, et al (2005). CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res, 574, 112-23.   DOI   ScienceOn
10 Cha IH, Park JY, Chung WY, et al (2007). Polymorphisms of CYP1A1 and GSTM1 genes and susceptibility to oral cancer. Yonsei Med J, 48, 233-9.   DOI   ScienceOn
11 Cheng L, Sturgis EM, Eicher SA, et al (1999). Glutathione-S-transferase polymorphisms and risk of squamous-cell carcinoma of the head and neck. Int J Cancer, 84, 220-4.   DOI   ScienceOn
12 Deng ZL, Yi-Ping Wei, Yun Ma (2005). Polymorphism of glutathione S-transferase mu 1 and theta 1 genes and hepatocellular carcinoma in southern Guangxi, China. World J Gastroenterol, 11, 272-4   DOI
13 Drummond SN, De Marco L, Noronha JC, Gomez RS (2004). GSTM1 polymorphism and oral squamous cell carcinoma. Oral Oncol, 40, 52-5.   DOI   ScienceOn
14 Egan KM, Cai Q, Shu XO, et al (2004). Genetic polymorphisms in GSTM1, GSTP1 and GSTT1 and the risk for breast cancer, results from Shanghai breast cancer study and meta analysis. Cancer Epidemiol Bio Prev, 13, 197-204.   DOI   ScienceOn
15 Acar H, Ozturk K, Muslumanoglu MH, et al (2006). Relation of glutathione S-transferase genotypes (GSTM1 and GSTT1) to laryngeal squamous cell carcinoma risk. Cancer Genet Cytogenet, 169, 89-93.   DOI   ScienceOn
16 Amtha R, Ching CS, Zain R, et al (2009). GSTM1, GSTT1 and CYP1A1 polymorphisms and risk of oral cancer: a casecontrol study in Jakarta, Indonesia. Asian Pac J Cancer Prev, 10, 21-6.
17 Nomura S, Sugano K, Kashiwabara H, et al (2000). Enhanced detection of deleterious and other germline mutations of hMSH2 and hMLH1 in Japanese hereditary nonpolyposis colorectal cancer kindreds. Biochem Biophys Res Commun, 271, 120-9.   DOI   ScienceOn
18 Olshan AF, Weissler MC, Watson MA, Bell DA (2000). GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev, 9, 185-91.
19 Gaudet MM, Olshan AF, Poole C, et al (2004). Diet, GSTM1 and GSTT1 and head and neck cancer. Carcinogenesis, 25, 735-40.
20 Gatta's GJ, de Carvalho MB, Siraque MS, et al (2006). Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck, 28, 819-26.   DOI   ScienceOn
21 Gronau S, Koenig-Greger D, Jerg M, Riechelmann H (2003). GSTM1 enzyme concentration and enzyme activity in correlation to the genotype of detoxification enzymes in squamous cell carcinoma of the oral cavity. Oral Dis, 9, 62-7.   DOI   ScienceOn
22 Guo X, Stephen J, O'Brien, et al (2008). GSTM1 and GSTT1 Gene Deletions and the Risk for Nasopharyngeal Carcinoma in Han Chinese. Cancer Epidemiol Biomarkers Prev, 17, 1760-3.   DOI   ScienceOn
23 Hahn M, Hagedorn G, Kuhlisch E, Schackert HK, Eckelt U (2002). Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to oral cavity cancer. Oral Oncol, 38, 486-90.   DOI   ScienceOn
24 Hamel N, Karimi S, He'bert-Blouin MN, et al (2000). Increased risk of head and neck cancer in association with GSTT1 nullizygosity for individuals with low exposure to tobacco. Int J Cancer, 87, 452-4.   DOI
25 Hanna E, MacLeod S, Vural E, Lang N (2001). Genetic deletions of glutathione-S-transferase as a risk factor in squamous cell carcinoma of the larynx: a preliminary report. Am J Otolaryngol, 22, 121-3.   DOI   ScienceOn
26 Evans AJ, Henner WD, Eilers KM, et al (2004). Polymorphisms of GSTT1 and related genes in head and neck cancer risk. Head Neck, 26, 63-70.   DOI   ScienceOn
27 Anantharaman D, Chaubal PM, Kannan S, Bhisey RA, Mahimkar MB (2007). Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis, 28, 1455-62.   DOI   ScienceOn
28 Park JY, Muscat JE, Ren Q, et al (2009). CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomarkers Prev, 6, 791-7.
29 Oude Ophuis MB, van Lieshout EM, Roelofs HM, Peters WH, Manni JJ (1998). Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions. Cancer, 82, 936-43.   DOI   ScienceOn
30 Park JY, Muscat JE, Kaur T, et al (2000). Comparison of GSTM polymorphisms and risk of oral cancer between African-American and caucasians. Pharmacogenetics, 10, 123-31.   DOI
31 Peters ES, McClean MD, Marsit CJ, Luckett B, Kelsey KT (2006). Glutathione S-transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal, and laryngeal carcinoma. Cancer Epidemiol Biomarkers Prev, 15, 2196-202.   DOI   ScienceOn
32 Risch A, Ramroth H, Raedts V, et al (2003). Laryngeal cancer risk in Caucasians is associated with alcohol and tobacco consumption but not modified by genetic polymorphisms in class I alcohol dehydrogenases ADH1B and ADH1C, and glutathione-S-transferases GSTM1 and GSTT1. Pharmacogenetics, 13, 225-30.   DOI   ScienceOn
33 Sato M, Sato T, Izumo T, Amagasa T (2000). Genetically high susceptibility to oral squamous cell carcinoma in terms of combined genotyping of CYP1A1 and GSTM1 genes. Oral Oncol, 36, 267-71.   DOI   ScienceOn
34 Schneider J, Bernges U, Philipp M, et al (2004). GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. Cancer Lett, 208, 65-74.   DOI   ScienceOn
35 Sharma A, Mishra A, Das BC, Sardana S, Sharma JK (2006). Genetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancer. Neoplasma, 53, 309-15.
36 Tiwawech D, Srivatanakul P, Karalak A, Ishida T (2005). Glutathione S-transferase M1 gene polymorphism in Thai nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 6, 270-5.
37 Sikdar N, Sila D, Badal D, et al (2005). Homozygous null genotype at glutathione S-transferase M1 locus as a risk factor for oral squamous cell carcinoma in Indian tobacco users. Int J Hum Genet, 5, 37-44.
38 Sreelekha TT, Ramadas K, Pandey M, et al (2001). Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol, 37, 593-8.   DOI   ScienceOn
39 Sugimura T, Kumimoto H, Tohnai I, et al (2006). Geneenvironment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms. J Oral Pathol Med, 35, 11-8.   DOI   ScienceOn
40 To-Figueras J, Gene' M, Go'mez-Catala'n J, et al (2002). Microsomal epoxide hydrolase and glutathione S-transferase polymorphisms in relation to laryngeal carcinoma risk. Cancer Lett, 187, 95-101.   DOI   ScienceOn
41 Toefil L, Oana CT, Horea AA, et al (2007). Head and neck cancer, epidemiology and histological aspects-Part 1, A decades results 1993-2003. J Cranio Maxill Surg, 35, 120-5.   DOI   ScienceOn
42 Topcu Z, Chiba I, Fujieda M, et al (2002). CYP2A6 gene deletion reduces oral cancer risk in betel quid chewers in Sri Lanka. Carcinogenesis, 23, 595-8.   DOI   ScienceOn
43 Toru H, Masaharu Y, Shinji T, et al (2008). Genetic polymorphisms and head and neck cancer risk. Int J Oncol, 32, 945-73.
44 Unal M, Tamer L, Ates NA, et al (2004). Glutathione S-transferase M1, T1, and P1 gene polymorphism in laryngeal squamous cell carcinoma. Am J Otolaryngol, 25, 318-22.   DOI   ScienceOn
45 Boccia S, Cadoni G, Sayed-Tabatabaei FA, et al (2008). CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer. J Cancer Res Clin Oncol, 134, 93-100.
46 Hayes JD, Pulford DJ (1995). The glutathione S-transferase supergene family, regulation of GST and the contribution of isoenzymes to cancer chemoprevention and drug resistance. Crit Rev Biochem Mol Biol, 30, 445-600.   DOI   ScienceOn
47 Bardakci F, Canbay E, Degerli N, Coban L (2003). Relationship of tobacco smoking with GSTM1 gene polymorphism in laringeal cancer. J Cell Mol Med, 7, 307-12.   DOI   ScienceOn
48 Bendjemana K, Abdennebi M, Gara S, et al (2006). Genetic polymorphism of gluthation-S transferases and N-acetyl transferases 2 and nasopharyngeal carcinoma: the Tunisia experience. Bull Cancer, 93, 297-302.
49 Bhurgri Y, Bhurgri A, Usman A, et al (2006). Epidemiological review of head and neck cancers in Karachi. Asia Pac J Cancer Prev, 7, 195-200.
50 Biselli JM, de Angelo Calsaverini Leal RC, Ruiz MT, et al (2006). GSTT1 and GSTM1 polymorphism in cigarette smokers with head and neck squamous cell carcinoma. Braz J Otorhinolaryngol, 72, 654-8.
51 Buch SC, Perin N (????). Notani and Rajani A. Bhisey Polymorphism at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis, 23, 803-7.
52 Cabelguenne A, Loriot MA, Stucker I, et al (2001). Glutathioneassociated enzymes in head and neck squamous cell carcinoma and response to cisplatinbased neoadjuvant chemotherapy. Int J Cancer, 93, 725-30.   DOI   ScienceOn
53 Cadoni G, Boccia S, Petrelli L, et al (2012). A review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolism. ACTA Otorhinolaryngologica Ita Lica, 32, 1-11.
54 Capoluongo E, Almadori G, Concolino P, et al (2007). GSTT1 and GSTM1 allelic polymorphisms in head and neck cancer patients from Italian Lazio Region. Clin Chim Acta, 376, 174-8.   DOI   ScienceOn
55 Xie H, Hou L, Shields PG, et al (2004). Metabolic polymorphisms, smoking, and oral cancer in Puerto Rico. Oncol Res, 14, 315-20.
56 Varela-Lema L, Taioli E, Ruano-Ravina A, et al (2008). Metaanalysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a huge-GSEC review. Genet Med, 10, 369-84.   DOI   ScienceOn